{"name":"Cellivery Therapeutics, Inc.","slug":"cellivery-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE00T0VTV3JJamJ0Mjg1U2tUUGhNak5jcXppejdTMVc0dVh0SHZmNTZYbzR4N2JJZDlzREtEczg0dXJrclRNNGpQN0ZSMnpNai1tTW91TF9YTzU4MHRZTUlpNnplWlNtb19zUV9nQ2dn0gFyQVVfeXFMT1I0aFBadkp3MnQ1bDdGVTctbXBrOEJGQ2ZVMTlfV3FkbTRsU21vWHZ5SktuZ3VfOVU5cFlvaVltVVBiQ2g5dVM0eUZmXzFkOHRjazJoVVlCZFdoSG00RkVvVXJXcGtIc3E4YWtkc1BLcWhB?oc=5","date":"2025-03-05","type":"pipeline","source":"koreabiomed.com","summary":"Cellivery fiasco exposes biotech market delusions and systemic failures - koreabiomed.com","headline":"Cellivery fiasco exposes biotech market delusions and systemic failures","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNZjVyUVRCNTZDcUxOYlNzd1dRSWZrUE1Qdlh1cEVNY2VHT0c0YU93U1ZuVnpCbzBlMDBkcUxGeHlFbktQbmhaQmpLOGF4bm92cDUxbHpTLUtlbzJ2amVnVy1ieXlsWElUcDRWQ0pYc1Q1N2c1R3hzS1lGcTM4R3dIV1hyTS1Ma0JCRlc5MGduX3V0REYxOVN3QmUwSVFReUVVX3VaUUV3SUJsTGlZTzYtZmFua0NIUnprUmp1V1N0amtUOHNzMTZPbEdQQkhpZ3NnYVI3cENlY25CcXktR3dmaFR0aGIzUExRaE95WmYwRzk1b0kzenNaLWVRMVk5Zw?oc=5","date":"2025-02-27","type":"pipeline","source":"GlobeNewswire","summary":"WEGOVY Marks Significant Growth in Market Share Across the 7MM for Obesity Treatment | DelveInsight - GlobeNewswire","headline":"WEGOVY Marks Significant Growth in Market Share Across the 7MM for Obesity Treatment | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxPTm1iOVZkUkcwdDV3cF90OEpGZ3VLbGdJQ0ZaWDNFa3BlMUF0ZS1CUTB5TWV2eHlFbkh1cXl6RjJFaHZlR1RVLVNTd1FDM19RRExiaEJIYndWWEk5ekp5aUlXNXRNbXFIYkFFUDlhOGdSRlRNZDlSN2IwekIyZ0ZES1FfdTVFY0JacTY3Z3Q3WE9kbUtERl9kVlFIY3Yzd2pqN19Wc1VHeHhNNU9ZZF9wa29qeDNDZC1wVFRFOGVSQTlRdTNNem5XRnJWR1lLNkRJOXBIZ2lSd0E0WU44dXhaaVo1dlkwdjR2Q3F6bUZkM3JkamtCTVYyMEhDQVRZLXBqd0VHWGctQmtLb2tyaC1mSk9RcEZVZ2RtUzdQZDRVcW9oLUV1VHMwbnVvczVlUUFTX3dz?oc=5","date":"2024-07-23","type":"trial","source":"GlobeNewswire","summary":"GLP Agonist Clinical Trial Pipeline Appears Robust With 20+ - GlobeNewswire","headline":"GLP Agonist Clinical Trial Pipeline Appears Robust With 20+","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-06-18","type":"pipeline","source":"prnewswire.com","summary":"Obesity Market to Observe Impressive Growth by 2034, Assesses DelveInsight | Key Companies - Novo Nordisk A/S, Pfizer, Boehringer Ingelheim, Eli Lilly and Company, Rhythm Pharmaceuticals, Harmony Bios","headline":"Obesity Market to Observe Impressive Growth by 2034, Assesses DelveInsight | Key Companies - Novo Nordisk A/S, Pfizer, B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE90NWR0enRnS2FleXdoZkRpUkJMVFBTQXEzWVBYVGhkLXZ3THUwRzY2UGs4bGdEd3NaS2IyXzBIUng1cng5M3JBTU9BX0dyeVViZXFHV2tZd1VFZkJjTEJUTWFyajBoRUV3MGJTTW130gFyQVVfeXFMUGRiVkxEcXhTTkg4Nk9VQVNFcnduRE5mWFJNR2FQRlRaekxJWnlCNEpnenlNWWZQb2F0QmE4TGgwbTlIZ2IybXpRUkY1VmRIMEtreGYzdEU1U3Rsa0pMZWVyV1Vzd0pEZTFzem9KdGdSazFR?oc=5","date":"2023-08-16","type":"pipeline","source":"koreabiomed.com","summary":"Cellivery faces delisting as it receives auditor’s ‘disclaimer of opinion’ for H1 - koreabiomed.com","headline":"Cellivery faces delisting as it receives auditor’s ‘disclaimer of opinion’ for H1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE0zZXpySlRuVTNjOGxGQUpYWHVjRWRVU1FQbFVIREg3LWxjRDJJSGZDT3NJM3hVS1hfMWxIUmNfd1BlS2tJdl8zQ1pINFpQZU9zeS1YVkRkOHMwTEMyelIzMVVNRnljMVczWUFuajVR0gFyQVVfeXFMTUc0T09xU1FYY0xDWlZvU3N6WXlhRUdReVNsTnJyMUUxUnNFb3MtbC1NTmRqQXRtVHhoUjB0OFUtbFZuNEZOaXpvSUFieG9Oamh4TWNfQVU2TnlMOFdSMi0wNmZfZ0t4TjBLUW5pMTdGY3hB?oc=5","date":"2023-04-11","type":"pipeline","source":"koreabiomed.com","summary":"Which are 8 Korean biotech firms that face delisting risk this year? - koreabiomed.com","headline":"Which are 8 Korean biotech firms that face delisting risk this year?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9ycnRkZVZ1MzJvakJfT0M2U0F5X3BDbGY5eW9VOG1wLUVsRVR5cVc3VzYwS0U1Vkx0NjFMcW1VTDByNW5EY2FRXy1kaHdZRlJabU1hTU1SbjV3SlRoZzkwd19DSVdxbVhtVHY5OEl30gFyQVVfeXFMT1FPQnhDZ042LVA2b1lQaVpZUHRBVmZSOGE2SkFneXF1NHBEU2U0WlNNZ3V4anloZWNsUHlGWFNkdVVxeEtTdTFhUUJpbzF1cUZMeGNyeVJ0Y1pib2ZqQWxOQkliYjVNRjU4TnlmM3h6N2F3?oc=5","date":"2021-06-28","type":"pipeline","source":"koreabiomed.com","summary":"Korean drug pipelines illuminated at global biotech convention - koreabiomed.com","headline":"Korean drug pipelines illuminated at global biotech convention","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBUQmVZQ1hkelhvTU1TTzN5WDFJYTFqQkRZbjdmTGRDblhrZ0ZWVEVUV0lJZVpBZlBsYjBCeU5aMkFKVWxvS1VaaW5MNTJsWkJzSUlr?oc=5","date":"2019-04-30","type":"pipeline","source":"The Korea Herald","summary":"Why do S. Korean pharma companies fund bio startups? - The Korea Herald","headline":"Why do S. Korean pharma companies fund bio startups?","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}